BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11603924)

  • 1. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
    J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R; Petrashevskaya N; Schwartz A; Aronow B; Boivin GP; Molkentin JD; Wieczorek DF
    Mol Cell Biochem; 2003 Sep; 251(1-2):33-42. PubMed ID: 14575301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
    Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
    Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
    Bing W; Knott A; Redwood C; Esposito G; Purcell I; Watkins H; Marston S
    J Mol Cell Cardiol; 2000 Aug; 32(8):1489-98. PubMed ID: 10900175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.
    Bing W; Redwood CS; Purcell IF; Esposito G; Watkins H; Marston SB
    Biochem Biophys Res Commun; 1997 Jul; 236(3):760-4. PubMed ID: 9245729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity.
    Stefanelli CB; Rosenthal A; Borisov AB; Ensing GJ; Russell MW
    Mol Genet Metab; 2004; 83(1-2):188-96. PubMed ID: 15464434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M; Pieples K; Rethinasamy P; Hoit B; Grupp IL; Boivin GP; Wolska B; Evans C; Solaro RJ; Wieczorek DF
    Circ Res; 1999 Jul; 85(1):47-56. PubMed ID: 10400910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
    Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
    Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
    Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic cardiac control in animal models of cardiovascular diseases II. Variability analysis in transgenic rats with alpha-tropomyosin mutations Asp175Asn and Glu180Gly.
    Wernicke D; Wessel N; Malberg H; Plehm R; Bauernschmitt R; Thierfelder L
    Biomed Tech (Berl); 2007 Feb; 52(1):50-5. PubMed ID: 17313334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-tropomyosin overexpression induces severe cardiac abnormalities.
    Muthuchamy M; Boivin GP; Grupp IL; Wieczorek DF
    J Mol Cell Cardiol; 1998 Aug; 30(8):1545-57. PubMed ID: 9737941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.